Company attributes
Industry
Location
B2X
Founder
Legal Name
Nightstar Therapeutics plc
Parent Organization
Legal classification
Date Incorporated
July 6, 2017
Number of Employees (Ranges)
11 – 50
Full Address
225 Binney Street Cambridge, MA 021420
9-10 Midford Place, London, England, W1T 5BJ
CIK Number
Place of Incorporation
Incorporation Reference
10852952
Investors
Founded Date
July 6, 2017
Total Funding Amount (USD)
172,000,000
Latest Funding Round Date
September 28, 2017
Stock Symbol
BIIB0
Exchange
Acquisition Transaction
Latest Funding Type
Country
Other attributes
Acquirer
Company Operating Status
Active
Previous Name
Nightstar Therapeutics Ltd0
SIC Code
2,8360
UKSIC Code
64209, 72110
Nightstar Therapeutics Limited was a gene therapy company developing treatments for patients suffering from rare inherited retinal diseases that lead to blindness. In March 2019, the company was acquired by Biogen.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
